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Abstract 
Introduction: Electrical storm is a life-threatening condition in an often medically complex patient 
population. Pharmacologic ultrasound-guided stellate ganglion blockade is a treatment option in 
combination with maximized systemic antiarrhythmic medications. There is an emerging body of case 
reports supporting stellate ganglion block efficacy and safety for this condition. 
Methods: Retrospective study on ultrasound-guided stellate ganglion blocks for electrical storm 
investigating patient clinical characteristics, immediate and long-term outcomes, and procedure related 
complications. 
Results: Four (75% men) critically ill patients maximized on standard antiarrhythmic therapy underwent 
six bedside ultrasound-guided stellate ganglion block procedures. All blocks were unilateral left-sided, two 
patients underwent repeat blocks for arrythmia reoccurrence. All patients experienced at least 12 hours 
free of ventricular arrhythmias with two thirds lasting beyond 24 hours. There were no observed 
complications. 
Conclusions: Ultrasound-guided stellate ganglion block is an effective and safe temporizing treatment 
option for electrical storm. Our institution-specific multidisciplinary guidelines were helpful in providing 
guidance for the use of stellate ganglion blocks in electrical storm. 
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Abstract
Introduction: Electrical storm is a life-
threatening condition in an often medically 
complex patient population. Pharmacologic 
ultrasound-guided stellate ganglion blockade 
is a treatment option in combination 
with maximized systemic antiarrhythmic 
medications. There is an emerging body of 
case reports supporting stellate ganglion block 
Methods: Retrospective study on 
ultrasound-guided stellate ganglion blocks 
for electrical storm investigating patient 
clinical characteristics, immediate and 
long-term outcomes, and procedure related 
complications.
Results: Four (75% men) critically ill patients 
maximized on standard antiarrhythmic 
therapy underwent six bedside ultrasound-
guided stellate ganglion block procedures. 
All blocks were unilateral and left-sided, 
with two patients undergoing repeat blocks 
for arrythmia reoccurrence. All patients 
experienced at least 12 hours free of 
ventricular arrhythmias with two-thirds lasting 
beyond 24 hours. There were no observed 
complications.
Conclusions: Ultrasound-guided stellate 
ganglion block is an effective and 
safe temporizing treatment option for 
multidisciplinary guidelines were helpful 
in providing guidance for the use of stellate 
ganglion blocks in electrical storm. 
Introduction
Electrical storm (ES) is a life-threatening 
condition associated with multiple episodes 
of ventricular arrhythmias resulting in 
hemodynamic instability and possibly 
therapy including shock or anti-tachycardia 
of this entity is when three or more separate 
ventricular arrhythmia episodes occur within 
a 24-hour period.1
ES is highly dependent upon the presence 
regard, 4 percent of post-infarction patients 
electrical storm.2
higher, at nine percent, in patients who have 
received placement of a left ventricular assist 
3 ES occurred 63% of the time 
3 The 
occurrence of ES in any patient is a serious 
mortality rates as high as 30% have been 
reported within 15 days of the arrhythmic 
event.3 
Standard therapy of ES typically involves 
suppression of arrhythmias by antiarrhythmic 
causes, mechanical cardiac support, cardiac 
ablation, and a reduction of sympathetic 
tone. Examples of reversible causes include 
decompensated heart failure, myocardial 
ischemia, metabolic disturbances, and 
tone reduction can be achieved by beta-
blockade and/or deep sedation, the latter 
requiring intubation and mechanical 
ventilation. Less commonly, alternative 
approaches such as thoracic epidural 
analgesia, surgical left sympathetic cardiac 
denervation, and percutaneous stellate 
ganglion pharmacologic blockade have been 
employed. Commonly, such options are not 
viable since these patients are frequently 
anticoagulated or hemodynamically unstable 
and unable to undergo a surgical procedure 
such as sympathectomy. 
Percutaneous stellate ganglion blockade for 
the treatment of ES has been reported in 
the literature mainly as retrospective case 
reports and small case series.4-9 Once a rare 
therapeutic intervention for ES, this novel 
approach to sympathetic tone reduction is 
emerging as a safe and effective treatment 
option for ES patients resistant to emergency 
intravenous drug therapy or for those 
requiring temporizing measures until a more 
ablation, can be performed. This article will 
review our recent institutional experience 
on the use of percutaneous stellate ganglion 
blockade in addition to standard treatment 
strategies. We report University of Nebraska 
Medical Center (UNMC) practice of utilizing 
ultrasound guided stellate ganglion block 
(USGB) for the treatment of ES and its effect 
period, incidence of block complications, and 
rate of survival to discharge. 
Materials and Methods
Design and Setting: This retrospective 
received an USGB for the treatment of ES 
from January 2018 through August 2019 at 
Board approved the study design and waived 
the need for patient consent. UNMC is an 
academic, quaternary-care institution with 
800 licensed beds and annually performs over 
200 catheter ablations, 50 ventricular assist 
devices, 80 ECMO cannulations, and 40 heart 
transplants. 
Study Population: Four patients who had 
within a 24-hour period were included in 
the study.10 Each patient received at least 
one USGB. Two patients received repeat 
USGBs. Patient demographic and clinical 
data was retrieved from the hospital electronic 
medical record. A thorough evaluation of the 
this review were progress notes, laboratory 
values, electrophysiology consult notes, 
implanted cardiac device interrogations, 
electrocardiograms, scanned telemetry 
strips, echocardiograms, pharmaceutical 
interventions, USGB and other operative 
procedures, procedural complications, 
discharge summaries, cardiac and respiratory 
events, and long-term outcomes. 
Arrhythmia Management: At UNMC, 
USGB treatment guidelines for electrical 
storm were developed in conjunction with our 
cardiac electrophysiologists (EP) (Table 1). 
These guidelines are utilized in conjunction 
with other standard measures such as 
identifying and treating reversible causes of 
intubation and deep sedation, antiarrhythmic 
cardiac support. 
USGB Procedure: Most stellate ganglion 
blocks are performed at UNMC for chronic 
pain related issues. The indication for these 
blocks typically allows for the block to be 
performed in an outpatient setting by our 
chronic pain service during regular clinic 
hours. However, patients suffering from 
electrical storm may require emergent stellate 
ganglion blockade. Therefore, our acute 
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pain service (APS) provides 24/7 coverage 
for these patients. Once a patient has been 
(EP), the acute pain service is consulted. At 
UNMC, acute pain service providers utilize 
ultrasound guidance for stellate ganglion 
block. Following our established USGB 
guidelines (Table 1), the patient must be in 
an intensive care setting where appropriate 
monitoring and vasopressor support is readily 
available. The blocks are performed by either 
a staff APS anesthesiologist or by a directly 
supervised senior anesthesiology resident on 
the APS service. All blocks are performed 
block is performed in order to reduce the risk 
of hypotension observed commonly with right 
sided and bilaterally SGB.11 During the lateral 
approach to the stellate ganglion, the operator 
uses a linear ultrasound probe 5-18 MHz 
(GE Logiq Er7) to identify carotid artery, left 
internal jugular vein, inferior thyroid artery, 
longus coli muscle, vertebral artery, anterior 
scalene muscle, prevertebral fascia, transverse 
and vertebral body of C6 and C7 (Fig. 1). 
intended needle trajectory to avoid inadvertent 
vascular puncture. The skin is anesthetized 
with 2-5 mL of 1% lidocaine. A 20-gauge, 
100mm nerve block needle (BBraun Ultraplex 
360®) is advanced in a posterior-to-anterior 
direction. Once the prevertebral fascia has 
been pierced a small amount of saline is 
used to hydro-dissect the fascial planes and 
verify appropriate needle tip location. After 
a negative aspiration, local anesthetic and 
dexamethasone are injected. Either the C6 or 
C7 vertebral body level is used based upon 
resolution and presence of vascular entities. 
As established in the USGB guidelines, if the 
patient does not experience response within 4 
hours, then a right sided block is performed. 
Bilateral blocks are only performed in 
intubated patients due to the risk of bilateral 
phrenic nerve palsy. The block is repeated 
at 24 and 72 hours dependent on the patient 
response and condition. 
Statistical Analysis: Descriptive statistics 
were utilized. Continuous data are presented 
as mean ±SD and categorical data are 
presented as numbers or percentages.
Results
A total of four patients (age, 63±9 years; 75% 
men) received a USGB for the diagnosis 
of electrical storm. The patients’ baseline 
demographic characteristics are shown 
in (Table 2). A total of six USGBs were 
performed. All patients received a left sided 
USGB. The preferred block solution was 10ml 
of 0.25% bupivacaine + 5mg dexamethasone 
the six blocks. Lipospheric bupivacaine 
39.9mg + 2ml 0.25% bupivacaine was used 
in one repeated block. The patients’ baseline 
demographic characteristics are shown 
in (Table 2). Three of the six blocks were 
performed on patients who were intubated, 
systemically anticoagulated, and receiving 
vasopressor support. The block was repeated 
received a bilateral USGB. No patient 
suffered from any block-related complication. 
No bleeding complications were noted 
considering half of the blocks occurred 
during therapeutic levels of anticoagulation. 
No block resulted in increased vasopressor 
dosage or initiation of vasopressor infusion. 
Figure 1. Ultrasound image for a left stellate ganglion block. SCM (sternocleidomastoid muscle), LCM 
(anterior scalene muscle), C7 body (C7 vertebral body), C7 TVP (C7 transverse vertebral process). 
Table 1. 
Guidelines for ultrasound-guided stellate ganglion block (USGB) blockade for Electrical Storm
EP cardiology will determine if a stellate ganglion block is indicated
APS will be consulted to urgently place the USGB 
Left sided SGB will initially be performed
Right-side USGB will be performed if no decrease in VA burden within 4 hours
USGB will be repeated at 24 hours and 72 hours
Prior response to laterality will determine subsequent laterality 
Need for repeat USGB after 72 hours will be determined by the EP cardiologist
APS provider will perform the USGB at bedside under the following conditions:
Intensive care setting
Standard monitors and ACLS resuscitative equipment
Norepinephrine solution at bedside 
Initial USGB will be performed with 0.25% bupivacaine, 10 ml per ganglion and 5 mg Dexamethasone per 
ganglion
Repeat block at 24 hours will be performed using only 0.25% bupivacaine PF, 10ml per ganglion
Dexamethasone 5 mg will only be utilized with the 1st block and at 72hours
EP= Electrophysiology
APS= Acute Pain Service
USGB= Ultrasound-guided stellate ganglion block
ACLS= Advanced cardiac life support
PF= Preservative free
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All individual blocks resulted in at least 
the individual blocks resulted in a 24-hour 
Two of the four patients were transitioned 
to compassionate withdrawal of care. This 
resulted in their death on post-operative 
day 3 and 5 respectively. These patients 
developed severe refractory biventricular 
failure and multi-organ dysfunction following 
their respective index surgeries: an on-pump 
multi-vessel coronary artery bypass grafting 
(CABG) and an ascending arch repair plus 
multi-vessel CABG with full circulatory 
arrest, respectively. Both patients received 
initiation of ECMO intraoperatively. Care 
was withdrawn by family due to futility of 
care in these patients. Notably, no death 
occurred within 48 hours of USGB. Of the 2 
surviving patients, one underwent successful 
ventricular ablation 2 days after the USGB. 
Both surviving patients ultimately underwent 
successful heart transplantation. 
Four patients underwent six successful USGB 
at our institution by the APS. All blocks were 
electrical criteria. No complications directly 
related to block placement were observed. 
reasons. First, in all patients, USGB was 
utilized for rescue in the context of maximal 
observed following each procedure with 
following block placement. Finally, half of 
our blocks were performed in patients who 
were systemically anticoagulated without 
notable bleeding complications. Taken in sum, 
we believe USGB to be a potentially viable 
therapeutic and safe intervention for rescue of 
refractory ES. 
No prospective randomized clinical trials 
of stellate ganglion block for the treatment 
retrospective case series employing stellate 
ganglion block as a treatment option for 
4,9,12 While randomized 
trials are always preferable and certainly 
needed, in this context, such a study would 
are critically ill and have maximized 
pharmacologic treatment and mechanical 
or life saving measure. 
The ability to provide a potentially 
lifesaving treatment option for patients 
suffering from ES was motivation for our 
team to develop clinical guidelines for 
the use of USGB at UNMC. Similar to 
other institutions’ protocols, the multi-
disciplinary guidelines were developed in 
junction with EP Cardiology, Acute Pain 
Anesthesiology, Critical Care Anesthesiology, 
and Cardiothoracic Surgery. These guidelines 
helped educate and inform providers as to 
the availability of the USGB as a treatment 
option in ES patients. Standardized guidelines 
based upon current literature helped to 
assure that the USGB was appropriately and 
maximally utilized at our training institution. 
For instance, many treatment providers do 
not consider the need for repeat or bilateral 
are the safety measures embedded in the 
guidelines assuring complications are avoided. 
The paucity of observed complications in 
our series is similar to other case reports. 
Currently, the largest published case series 
of 30 patients involving 38 blocks reported 
a solitary complication of a sore throat after 
SGB, notable considering 50% of the patients 
were fully anticoagulated with warfarin 
at time of the procedure.9 Most reported 
procedure operators were anesthesiologists. 
One case series of similar size to ours was 
performed by EP cardiologists4. Compared 
to other studies, the observed 50% mortality 
to interpret due to the premorbid condition of 
two of our patients.
been reported in prior studies which 
typically included bupivacaine or lidocaine 
alone or in varying combinations without 
standardization.4,9 However, we chose to 
fraction
INR= international normalized ratio
VT= ventricular tachycardia
VT + VF= ventricular tachycardia 
ATP= antitachycardia pacing
IABP= intra-aortic balloon pump
LVAD= left ventricular assist device







Characteristics  Totals 
# of patients 4
Gender male 75%
Age 63±9








Prior Ventricular arrhythmias 50%












VT + VF 33%
Diagnosis of electrical storm 100%
Episodes of VT/VF PRE-block 5±3
Number of ICD, external 






Intubation pre block 67%
Characteristics  Totals 
Pharmaceutical intervention
Deep sedation 67%
No. of antiarrhythmic drugs 2.8±0.4
Vasopressor support pre-block 50%
No. of vasopressor drugs 0.8±1.2
Vasopressor support increased 
or initiated immediately 
following block
0%




Hospital death within 72 hrs of 
block
25%
Survival to discharge 50%
Survival at 3 months 50%




# USGB performed 6
# Repeated blocks 2
Supervised resident performed 50%
Unilateral left side SGB 100%
Bilateral SGB 0%
Block complication 0%
Horners syndrome documented 33%
USGB solution used: 10ml 
0.25% bupivacaine + 5mg 
dexamethasone
83%
Period of VA free time post 
block (hrs)
55±78
% of blocks resulting in a 12 hr 
VA free period
100%
% of blocks resulting in a 24 hr 
VA free period
67%
% of blocks resulting in a 48 hr 
VA free period
17%
% of blocks resulting in a 72hr 
VA free period 
17%
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standardize our block medications. Five 
of the 6 blocks were performed using 10 
ml of 0.25% bupivacaine plus 5 mg of 
dexamethasone. Dexamethasone was added 
to our block mixture based upon research 
in the stellate ganglion contributes to 
arrhythmogenesis in bleomycin-induced acute 
lung injury.13 The use of dexamethasone as an 
adjuvant for nerve blocks is quite common. 
However, the underlying mechanism of 
prolonged nerve blockade is not clearly 
the medication would reduce stellate neuro-
excitation through its macrophage inhibitory 
effects thereby reducing the need for repeated 
USGB. 
was similar to other reports.9,14 One patient 
received lipospheric bupivacaine and 
bupivacaine HCL because of worsening 
severe coagulopathy and it was felt that the 
opportunity to safely repeat a block would 
not exist. This patient had resolution of 
recurred in the operating room with direct 
ECMO decannulation. However, the patient 
the hospitalization. The use of lipospheric 
bupivacaine for a stellate ganglion block has 
been reported one other time in literature.15 
The focus of promoting a sodium channel 
blockade at the stellate ganglion using local 
anesthetics could be augmented by the 
addition of clonidine which has been reported 
16
Study Limitations
This small case series study is limited by 
its retrospective design. The complex and 
somewhat premorbid patient population also 
varied with respect to concurrent medical 
mechanical circulatory support, use of 
general anesthesia, and attempts at catheter 
ablation. Even though guidelines exist at 
our institution, the guidelines were adjusted 
based upon the patients’ unique clinical status 
and treating providers’ personal bias and 
comfort with the use of USGB. However, 
these guidelines provided a general basis of 
agreement and possibly a standard of care 
which can be applied to future randomized 
of documentation of Horner’s Syndrome or 
ipsilateral extremity temperature change. 
Documentation of Horner’s Syndrome 
only occurred in two of the six blocks. This 
may not be as important since ultrasound 
guidance allows for real-time visualization 
of local anesthetic deposit and has been 
shown to reliably provide stellate blockade 
when compared to stellate ganglion block 
using anatomic landmarks.17
at our facility is the fact that our telemetry 
monitoring system does not allow for 
retrospective review of raw continuous data. 
Telemetry strips are printed and manually 
scanned into the patient chart (Fig 2.) 
making statistical analysis of continuous data 
including 24-hour ventricular arrhythmias 
burden impossible. 
Conclusions
period in 4 of 4 patients who were suffering 
from electrical storm. None of these complex 
patients incurred complications related to 
the block. USGB should be considered as a 
safe adjunctive therapy for patients suffering 
from electrical storm who are maximized 
guidelines for the use of stellate ganglion 
block should be established to standardize and 
safely accomplish this procedure. 
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